Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Dow
Express Scripts
Mallinckrodt
Johnson and Johnson

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation (D. Mass. 2014)

See Plans and Pricing

« Back to Dashboard

In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation (D. Mass. 2014)

Docket   Start Trial Date Filed 2014-02-25
Court District Court, D. Massachusetts Date Terminated 2018-07-18
Cause 15:1 Antitrust Litigation Assigned To Denise Jefferson Casper
Jury Demand Both Referred To Jennifer C. Boal
Parties AHOLD U.S.A., INC.; ALBERTSON'S LLC; ALLIED SERVICES DIVISION WELFARE FUND; BARR LABORATORIES, INC.; CALIFORNIA PHYSICIANS' SERVICE D/B/A BLUE SHIELD OF CALIFORNIA; CITY OF PROVIDENCE, RHODE ISLAND; CONSOLIDATED PLAINTIFFS; CVS PHARMACY, INC.; DEFENDANTS; DIRECT PURCHASER PLAINTIFFS; FRATERNAL ORDER OF POLICE, FORT LAUDERDALE LODGE 31; HEATHER MORGAN; HEB GROCERY CO. LP; IMPAX LABORATORIES, INC.; INTERNATIONAL UNION OF OPERATING ENGINEERS LOCAL 132 HEALTH AND WELFARE FUND; INTERNATIONAL UNION OF OPERATING ENGINEERS STATIONARY ENGINEERS LOCAL 39 HEALTH & WELFARE TRUST FUND; LOCAL 274 HEALTH & WELFARE FUND; LUPIN LIMITED; LUPIN PHARMACEUTICALS, INC.; MAN-U SERVICE CONTRACT TRUST FUND; MATRIX LABORATORIES LTD.; MEDICIS PHARMACEUTICAL CORP.; MYLAN INC.; NATIONAL MEDICAL HEALTH CARD SYSTEMS, INC.; NECA-IBEW WELFARE TRUST FUND; OPTUMRX, INC.; PAINTERS DISTRICT COUNCIL NO. 30 HEALTH AND WELFARE FUND; PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH AND WELFARE TRUST FUND; RANBAXY INC.; RANBAXY LABORATORIES, LTD; RANBAXY PHARMACEUTICALS, INC.; RITE AID CORPORATION; RITE AID HDQTRS. CORP.; ROCHESTER DRUG CO-OPERATIVE, INC.; SAFEWAY, INC.; SANDOZ INC.; SHEET METAL WORKERS LOCAL NO. 25 HEALTH & WELFARE FUND; SOLODYN (MINOCYCLINE HYDROCHLORIDE) ANTITRUST LITIGATION; TEVA PHARMACEUTICALS USA INC; THE KROGER CO.; UNITED FOOD AND COMMERCIAL WORKERS LOCAL 1776 & PARTICIPATING EMPLOYERS HEALTH AND WELFARE FUND; UNITED HEALTHCARE SERVICES, INC.; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; WALGREEN CO.
Patents 5,908,838; 7,541,347; 7,544,373; 7,790,705; 7,919,483; 8,039,009; 8,252,776; 8,268,804
Attorneys Abram J. Ellis; Adam E. Polk; Adam Giffords Kurtz; Adrienne Vollmer Baxley; ALEXANDER L. HARRIS; Alfred Luke Smith; Andrew C. Curley; ANDREW M. LACY; Andrew T. Hernacki; Anjali B. Patel; Anna Fabish; Anna T. Neill; Anne K. Fornecker; April D. Lambert; Archana Tamoshunas; ARKADY ERIC RAYZ; AUDREY WALTON-HADLOCK; BARBARA T. SICALIDES; Barry L. Refsin; Barry S. Taus; Benedict Y. Hur; BRENT W. LANDAU; Caitlin G. Coslett; Caroline P. Gately; Christian R. Jenner; Christina C. Sharp; Christopher G. Clark; CHRISTOPHER J. CAHILL; Christopher T. Holding; Daniel C. Girard; Daniel C. Simons; DANIEL J. BOLAND; Daniel M. Gonzales; Daniel P. Thiel; Daniel Rubenstein; Daniel Walker; Danielle R. Foley; David A. Levie; David B Rosenbaum; David B. Franco; David F. Sorensen; David R. Cheverie; David S. Nalven; David Scott Scalia; Derek Brandt; Diana C. Wielocha; Donald Sean Nation; Donna M. Evans; Douglas R. Plymale; ELI EWING; Eric L. Bloom; Erin Durba; Frazar Wright Thomas; Glen DeValerio; Grace V. Bacon Garcia; Gregory Linkh; J. Douglas Richards; Jacob A. Goldberg; James Douglas Baldridge; James J Belanger; James R. Carroll; James R. Dugan , II; Jamie R Kurtz; Jay P. Lefkowitz; Jayne A. Goldstein; JEANNINE M. KENNEY; Jeffrey S. Gleason; JEFFREY S. ISTVAN; JENNIFER RIE; Jessica A. Swauger; Jessica Rose MacAuley; John A. Ioannou; John G. Harkins , Jr.; JOSEPH E. WOLFSON; Joseph L Demeo; Joseph Nathaniel Roth; Joseph Serino , Jr.; Joseph T. Lukens; Julia K. York; Justin P. O'Brien; Karen Leser-Grenon; Katelyn B. Benton; KATHERINE L. CHILDERS; Katherine Louise DeStefano; Katherine M. Wright; Kathleen A. Federico; Katie Glynn; Keith Beauchamp; KENNETH R. O'ROURKE; Kevin M. McGinty; Kiersten Taylor; Krishna B. Narine; Kristin M. Koger; Lance Oliver; Lanson Leon Bordelon; LAURA KILLIAN MUMMERT; Lauren C. Ravkind; Lauren G. Barnes; Laurence A. Schoen; Lawrence S. Delaney; Lee Albert; LEIV H. BLAD; Lisa Jose Fales; Marc I. Gross; Mark Bryan Goldstein; Matthew D. Kent; Matthew E. Van Tine; Matthew F Dexter; Maureen S. Lawrence; Michael Coren; Michael John Rusing; Michael Louis Whitlock; Michael M. Buchman; Michael P. Kenny; Mitchell Mark Breit; Monica L. Kiley; Natalie Finkelman Bennett; Nathaniel L. Orenstein; Neill C. Kling; Neill Clark; Norman Berman; PAUL COSTA; Paul Feinstein; PAULA L. BLIZZARD; Peter C. Thomas; Peter Kohn; Peter N. Foundas; RAVI R. SHARMA; Richard Alan Arnold; Robert D. Carroll; ROBERT N. FELTOON; Robert S. Kitchenoff; Roberta D. Liebenberg; ROBIN LOCKE NAGELE; Ross L Weiner; Rudy Gonzales, Jr.; Samuel R. Rowley; Sara L. Bensley; Sarah Jeanne Stanton; Sarah K. Frederick; Scott E. Perwin; Sean M. Tepe; Sharon K. Robertson; Stephen J. McIntyre; Steve D. Shadowen; STEVEN C. SUNSHINE; Stewart L. Cohen; Stuart B. Baimel; Tara L. Reinhart; Tara Reinhart; Teresa T. Bonder; Theodore M. Hess-Mahan; Thomas G. Shapiro; Thomas M. Sobol; Timothy John Reckart , Sr.; Vincent E. Verrocchio; William H. Kettlewell; William K. Wray , Jr.; William R. Landry; William S Hicks; XAVIER BLAKE SPARROW; Zarema A. Jaramillo
Firms Alexander L. Harris; Alston & Bird; Alston & Bird LLP; Andrews DeValerio LLP; Berger & Montague PC; Berger & Montague, P.C.; Berger & Montague, PC; Blish & Cavanagh; Cohen Milstein Sellers & Toll PLLC; Conrad O'Brien; Coppersmith Brockelman PLC; David A. Levie; Demeo LLP; Faruqi and Faruqi LLP; Fine Kaplan and Black, RPC; Fine, Kaplan & Black, Rpc; FrancoLaw, PLLC; Girard Gibbs; Girard Gibbs LLP; Glancy Prongay and Murray LLP; Goldman Scarlato Karon & Penny PC; Goodwin Procter LLP; Hach Rose Schirripa & Cheverie LLLP; Hagens Berman Sobol Shapiro LLP; Hangley Aronchick Segal Pudlin & Schiller; Hangley Aronchick Segal Pudlin and Schiller; Hangley Aronchick Segal Pudlin& Schiller; Hangley, Aronghick, Segal , Pudlin & Schiller; Hausfeld LLP; Hilliard & Shadowen LLC; Hilliard & Shadowen LLP; Hilliard Martinez Gonzales LLP; Hilliard Shadowen, LLP; Hogan Lovells US LLP; Hutchings, Barsamian, Cross and Mandelcorn, LLP; Jamie R Kurtz; Jeffrey S. Gleason; John G. Harkins , Jr.; Kalikhman & Rayz LLC; Keker & Van Nest LLP; Keker, Van Nest & Peters LLP; Kirkland & Ellis LLP; Kirkland & Ellis LLP - New York, NY; Lauren C. Ravkind; Lowenstein Sandler LLP; Milberg LLP (NYC); Miller Law LLC; Morgan, Lewis & Bockius LLP; Morrison Mahoney LLP; Motley Rice LLC; Murray Frank and Sailer; Neill C. Kling; O'Melveny & Myers LLP; Osborn Maledon PA; Pomerantz LLP; Pomerantz, LLP; Post & Schell, Pc; Radice Law Firm PC; Radice Law Firm, PC; Richard Alan Arnold; Robins Kaplan LLP; Rusing Lopez & Lizardi, P.L.L.C.; Sarah K. Frederick; Schiffrin & Barroway; Scott E. Perwin; Shepherd Finkelman Miller & Shah LLP; Shepherd, Finkelman, Miller & Shah, LLP; Shephere, Finkelman, Miller & Shah, LLP; Simmons Browder Glanaris Angelides & Barnerd; Simpson Thacher & Barlett LLP; Simpson Thacher & Barlett, LLP; Simpson Thacher & Bartlet LLP; Simpson Thacher & Bartlett LLP; Simpson Thacher & Bartlett, LLP; Simpson Thacher and Bartlett LLP; Skadden Arps Slate Meagher & Flom LLP; Skadden Arps Slate Meagher and Flom LLP; Skadden, Arps, Slate, Meagher & Flom; Taus, Cebulash & Landau; Taus, Cebulash & Landau, LLP; The Dugan Law Firm; The Rosen Law Firm PA; Venable LLP; Weinstein Kitchenoff & Asher LLC
Link to Docket External link to docket
Small Molecule Drugs cited in In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation (D. Mass. 2014)

Date Filed Document No. Description Snippet Link To Document
2017-11-21 769 related to one of those patents—U.S. Patent No. 5,908,838 (the "'838 Patent"). Thomas…373, '705, and '776 Patents. As for validity of the '838 Patent, Thomas opines that 1111 …Thomas' testimony on patent validity due to objections that it was "patently inappropriate"…non-infringement of the '838 Patent, (b) validity and infringement of the Solodyn Patents, (c) inequitable conduct…Solodyn Patent, (d) Medicis' likelihood of success in litigation over the Solodyn Patents, (e) a External link to document
2017-11-22 780 power and the infringement of U.S. Patent 5,908,838 (the “’838 patent”). II. STANDARD OF REVIEW…infringement of the ’838 patent. Accordingly, Defendants cannot establish that the ’838 patent would have prevented… 1. The ’838 Patent. The ’838 patent issued on June 1, 1999. 37 It covers…838 patent contained two independent and sixteen dependent claims. 39 The ’838 patent was… Medicis with respect to the ’838 patent, claiming that the patent was either invalid or Impax did not External link to document
2018-01-12 931 including U.S. Patent No. 5,908,838 (“’838 patent”) and U.S. Patent No. 7,790,705 (“’705 Patent”). Additionally…U.S. Patent No. 7,541,347 (“’347 Patent”), U.S. Patent No. 7,544,373 (“’373 Patent”), U.S. Patent No. …7,919,483 (“’483 Patent”), U.S. Patent No. 8,268,804 (“’804 Patent”), and U.S. Patent No. 8,252,776 (“…expert, a patent law professor, to opine on a patent litigant’s chances of success in a patent suit), aff…infringement of Medicis’s patents, as well as the timeline for Impax-Medicis patent litigation. Defendants External link to document
2018-01-25 948 30. Medicis holds U.S. Patent No. 5,908,838 (the “’838 patent”), a “[m]ethod for the [t]reatment…issued an additional patent to Medicis—U.S. Patent No. 7,790,705 (the “’705 patent”), covering “the method…reexamination of the ’838 patent, and in June 2010, the United States Patent …the ’838 patent was invalid for obviousness. D. 850 at 17. Subject matter cannot be patented if “the …analyses of multiple Solodyn patents; it is not specific to the ’838 patent. See Kibbe 19 Kibbe’s External link to document
2018-01-25 963 if additional information had been submitted.8' 9 Id. at *18-21. Accordingly, Plaintiffs' cases…FOR THOMAS'S OPINION ON TECHNICAL PATENT ISSUES Patent law experts are not qualified to opine…expert to opine on the validity of [the] patent was patently inappropriate and frivolous" and then…"patent law expert [mayj 'opine on whether a certain criteria is material to a Patent Office…not merely a "patent law expert," but also a former Solicitor of Patents and Trademarks at External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
McKinsey
Express Scripts
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.